D. Vo

发表

Bacterial two-component signalling as a therapeutic target in drug design. Inhibition of NRII by the diphenolic methanes (bisphenols).

J. Domagala, M. Cummings, D. Alessi, 1998, Advances in experimental medicine and biology.

Anti-tumor activity and trafficking of self , tumor-specific T cells against tumors located in the brain , a , b

L. Liau, A. Ribas, H. Soto, 2009 .

Broad antitumor protection by dendritic cells administered to CD8α knock out mice

B. Comin-Anduix, A. Ribas, W. McBride, 2006, Cancer Immunology, Immunotherapy.

T cell receptor (TCR)-transgenic CD8 lymphocytes rendered insensitive to transforming growth factor beta (TGFβ) signaling mediate superior tumor regression in an animal model of adoptive cell therapy

T. Chatila, W. McBride, D. Vo, 2012, Journal of Translational Medicine.

Isoform-level transcriptome-wide association uncovers extensive novel genetic risk mechanisms for neuropsychiatric disorders in the human brain

B. Pasaniuc, M. Gandal, D. Vo, 2022, medRxiv.

NK and CD 4 Cells Collaborate to Protect against Melanoma Tumor Formation in the Brain 1

L. Liau, A. Ribas, H. Soto, 2006 .

NK and CD4 Cells Collaborate to Protect against Melanoma Tumor Formation in the Brain1

L. Liau, A. Ribas, H. Soto, 2006, The Journal of Immunology.

Immunosensitization with a Bcl-2 small molecule inhibitor

A. Ribas, Stephen Mok, D. Vo, 2009, Cancer Immunology, Immunotherapy.

Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads.

R. Seeger, D. Vo, C. Reynolds, 1986, Cancer research.

Depletion of neuroblastoma cells from bone marrow with monoclonal antibodies and magnetic immunobeads.

R. Seeger, D. Vo, C. Reynolds, 1985, Progress in clinical and biological research.

Removal of neuroblastoma cells from bone marrow with monoclonal antibodies and magnetic immunobeads.

R. Seeger, D. Vo, C. Reynolds, 1986, Progress in clinical and biological research.

Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824.

F. Marincola, A. Ribas, E. Wang, 2009, Cancer Research.

Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brain

L. Liau, A. Ribas, O. Witte, 2008, Cancer Immunology, Immunotherapy.

Quantitative PET reporter gene imaging of CD8+ T cells specific for a melanoma-expressed self-antigen

M. Phelps, A. Ribas, O. Witte, 2008, International immunology.

A RecA Protein Surface Required for Activation of DNA Polymerase V

R. Woodgate, M. Cox, D. Vo, 2015, PLoS genetics.

Immunosensitization of Tumor Cells to Dendritic Cell-Activated Immune Responses with the Proteasome Inhibitor Bortezomib (PS-341, Velcade)1

B. Comin-Anduix, A. Ribas, W. McBride, 2006, The Journal of Immunology.

Conformational regulation of Escherichia coli DNA polymerase V by RecA and ATP

R. Woodgate, F. Pinaud, M. Cox, 2019, PLoS genetics.

A Histone Deacetylase Inhibitor (HDACI) Sensitizes B16 Melanoma to Adoptive Transfer (AT) Immunotherapy

A. Ribas, D. Vo, J. Economou, 2006 .

Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824.

F. Marincola, A. Ribas, E. Wang, 2009, Cancer research.